BackEiger BioPharmaceuticals Overview

Eiger BioPharmaceuticals Operating Income

Operating Income for EIGR.

Quarterly Operating Income

$-12614000.00
↓ 48.45% YoY

As of Dec 31, 2023

Annual Operating Income (TTM)

$-71786000.00
↓ 22.59% YoY

Trailing 12 months ending Dec 31, 2023

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin